Genomic Solutions awarded patent for novel technology.Genomic Solutions, Inc. (Ann Arbor Ann Arbor, city (1990 pop. 109,592), seat of Washtenaw co., S Mich., on the Huron River; inc. 1851. It is a research and educational center, with a large number of government and industrial research and development firms, many in high-technology fields such as , MI; 734-975-4800), announced that the United States Patent and Trademark Office The United States Patent and Trademark Office (PTO or USPTO) is an agency in the United States Department of Commerce that provides patent protection to inventors and businesses for their inventions, and trademark registration for product and intellectual property has awarded the company a significant patent . The United States Patent 6,302,159, entitled "Apparatus and method of carrying out flow through chemistry of multiple mixtures," describes a device and techniques to facilitate processing of solid-liquid mixtures in high throughput proteomic research. Pharmaceutical and biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. researchers continually seek new methods for rapidly identifying therapeutically important proteins. The company's Investigator ProPREP and Investigator ProGEST instruments employ this newly patented, novel approach to accelerate and automate protein digestion in preparation for mass spectrometry mass spectrometry or mass spectroscopy Analytic technique by which chemical substances are identified by sorting gaseous ions by mass using electric and magnetic fields. analysis. "This breakthrough design lies at the heart of the new Investigator ProPREP, enabling the instrument to complete protein digestion with no aspiration steps, thus eliminating cross contamination cross contamination Medical practice The passsage of pathogens indirectly from one Pt to another due to use of improper sterilization procedures, unclean instruments, or recycling of products concerns. This novel technology enables proteomic life science researchers to gain greater automation capabilities, improved sensitivity and contamination free processing," notes David Miller, Proteomic Global Product Manager. "We are pleased to add this patent to our expanding portfolio of intellectual property," Mr. Miller continued. "The company is dedicated to developing next generation proteomic research systems. The implementation of this unique approach affirms our dedication of the company's research and development resources to proteomics. We have been quite pleased with the feedback received from our initial Investigator ProPREP product users, who represent several thought leaders in proteomic research," notes Jeffrey S. Williams, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . The company designs, develops, manufactures, markets and sells instruments, software, consumables and services used to determine the activity level of genes and to isolate, identify and characterize proteins. The company's products and systems, marketed under the GeneTAC Biochip biochip Small-scale device, analogous to an integrated circuit, constructed of or used to analyze organic molecules associated with living organisms. One type of theoretical biochip is a small device constructed of large organic molecules, such as proteins, and capable of System, Investigator Proteomics System and GeneMAP preprinted arrays brands, enable researchers to perform complex, high volume experiments at a lower cost and in less time than traditional techniques. As a result, Genomic Solutions products and systems facilitate more rapid and less expensive drug discovery. |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion